Skip to content

NVO

Novo Nordisk A/S

NYSE · Healthcare · Drug Manufacturers - General · DK

$43.24
+0.12%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 4, 2026
EPS estimate
$0.80
Revenue estimate
$11.2B

Latest reported

Last report date
Aug 5, 2026
EPS actual
$0.96
EPS estimate
$0.77
Revenue actual
$12.1B
Revenue estimate
$10.9B

Track record

Trailing twelve quarters

EPS beats (12Q)
8
EPS misses (12Q)
1
EPS in line (12Q)
3
Avg surprise (4Q)
+21.9%
Revenue beats (12Q)
8
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 5, 2026$0.77$0.96Beat 24.68%$12.1B
May 6, 2026$0.87$1.04Beat 19.54%$11.0B
Feb 4, 2026$0.90$1.00Beat 11.11%$12.3B
Nov 5, 2025$0.77$1.02Beat 32.47%$11.8B
Aug 6, 2025$0.93$0.97Beat 4.30%$12.1B
May 7, 2025$0.92$0.92In line$11.5B
Feb 5, 2025$0.88$0.91Beat 3.41%$11.9B
May 2, 2024$0.75$0.82Beat 9.79%$9.4B
Jan 31, 2024$0.65$0.71Beat 9.71%$9.7B
Nov 2, 2023$0.71$0.71Beat 0.42%$8.3B
Aug 10, 2023$0.67$0.63Miss -5.41%$7.9B
May 4, 2023$0.63$0.63Beat 0.48%$7.8B

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026